Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Generic antidiabetic agent approved by FDA

Jan. 3, 1997

FDA advisory panel to discuss penile implant guidelines

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Fluoxetine plus dexfenfluramine effective in obese patients

Jan. 3, 1997

Lilly claims IGF-1 superagonists

Jan. 3, 1997

New vitamin D derivatives from Duphar

Jan. 3, 1997

Japanese researchers focus on pyripyropenes

Jan. 3, 1997

Norian begins trial of Norian SRS in hip fractures

Jan. 2, 1997

Osiris provides funds for clinical trial of hMSCs

Jan. 2, 1997

Novo Nordisk clear to market hGH product in U.S.

Jan. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...